InterVenn® Biosciences announced the start of enrollment in its prospective cohort study for early detection of colorectal cancer and adenomas.
[InterVenn® Biosciences (Business Wire, Inc.)]
Home Newsletters Intestinal Cell News InterVenn Biosciences Announces Start of Enrollment in Colonoscopy Study
